Search
SP-8203
go.drugbank.com/drugs/DB11670InvestigationalSP-8203 has been used in trials studying the treatment of Ischemic Stroke.
Categories: Heterocyclic Compounds, 2-RingAZD-4877
go.drugbank.com/drugs/DB11671InvestigationalAZD4877 has been used in trials studying the treatment of NHL, Tumors, Cancer, Lymphoma, and Neoplasms, among others.
Categories: Heterocyclic Compounds, 1-RingPF-06282999
go.drugbank.com/drugs/DB11683InvestigationalPf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects).
Categories: Heterocyclic Compounds, 1-RingVonapanitase
go.drugbank.com/drugs/DB11690InvestigationalVonapanitase is under investigation for the treatment of Chronic Kidney Disease.
Amenamevir
go.drugbank.com/drugs/DB11701InvestigationalAmenamevir has been used in trials studying the treatment of Herpes Zoster, Herpes Simplex, Herpes Genitalis, and Safety of Amenamevir.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A InducersAcetyl hexapeptide-3
go.drugbank.com/drugs/DB11709InvestigationalArgireline has been used in trials studying the treatment of wrinkles.
Synonyms: Hexapeptide 3, Acetyl hexapeptide-3Mixtures: HydroGold 9Trigonellamide
go.drugbank.com/drugs/DB11710InvestigationalTrigonellamide is under investigation in clinical trial NCT01930240 (The Safety of a Hypolipidemic Agent in Healthy Normal Volunteers).
Synonyms: 1-MNACategories: Heterocyclic Compounds, 1-RingNavarixin
go.drugbank.com/drugs/DB11711InvestigationalNavarixin has been investigated for the treatment of Asthma.
Categories: Heterocyclic Compounds, 1-RingRuzasvir
go.drugbank.com/drugs/DB11713InvestigationalRuzasvir has been used in trials studying the treatment of Hepatitis C, Hepatitis C, Chronic, and Hepatitis C Infection.
Categories: Heterocyclic Compounds, 1-RingDurvalumab
go.drugbank.com/drugs/DB11714ApprovedInvestigationalDurvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody and a novel immune-checkpoint inhibitor for cancer treatment. … small cell lung cancer (ES-SCLC).
Categories: PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors, PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitorsProducts: IMFINZI® 50 MG/ML CONCENTRADO PARA SOLUCIÓN PARA INFUSIÓN, IMFINZI 120 MG/2.4 ML İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN KONSANTRE, 1 ADET